Circulating ICAM-1, VCAM-1, E-selectin, P-selectin, and TNFalphaRII in patients with coronary artery disease

M Hajilooi1, A Sanati, A Ahmadieh

  • 1Department of Immunology, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Serum soluble intercellular adhesion molecule-1 (sICAM-1) is linked to coronary artery disease. Measuring sICAM-1 may enhance risk assessment for coronary artery disease in Iranian patients.

Area of Science:

  • Cardiovascular Research
  • Biomarker Discovery
  • Inflammation and Atherosclerosis

Background:

  • Coronary artery disease (CAD) involves complex inflammatory processes.
  • Adhesion molecules play a crucial role in the pathogenesis of atherosclerosis.

Purpose of the Study:

  • To investigate the association between serum levels of TNFalphaRII and adhesion molecules (ICAM-1, VCAM-1, P-selectin, E-selectin) with coronary artery stenosis.
  • To determine the potential of these markers in predicting CAD risk.

Main Methods:

  • Cross-sectional observational study involving 81 CAD patients and 75 controls.
  • Enzyme-linked immunosorbent assay (ELISA) used to quantify serum soluble adhesion molecules and TNFalphaRII.
  • Statistical analyses including logistic regression and multiple regression were performed.

Main Results:

  • Significantly higher serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble P-selectin were observed in CAD patients compared to controls.
  • sICAM-1 was identified as an independent risk factor for CAD.
  • sP-selectin levels were elevated in patients with single-vessel disease.

Conclusions:

  • Serum sICAM-1 is associated with stable coronary artery disease.
  • sICAM-1 evaluation may improve coronary risk assessment, particularly in the Iranian population.
  • Further research into adhesion molecules as CAD biomarkers is warranted.
Abstract